This small-cap stock jumps nearly 1% after East Lane Capital Bought 1.5 lakh shares via a block deal. The stock has delivered 37% returns in six months and 34% returns in one year to the investors. The stock is trading 3.3% below the 52-week high and 14.7% & 32.4 above the 50-day and 200-day moving averages.
Krsnaa Diagnostics Ltd the company has a market capitalisation of Rs. 2,116 Cr making it a small-cap company. On Wednesday at 15:10 p.m., shares were trading 0.8% down at Rs. 677.10 on NSE.
According to the NSE bulk deal data, East Lane Capital LLP bought 1.5 lakh shares which is 0.47 of the equity at Rs. 675 per share and Medimaze Solutions Pvt Ltd sold 1.5 lakh shares at the same price.
As per the company filing, total revenues declined by 22.4% from Rs. 117.4 Cr in Q1 FY23 to Rs. 143.8 Cr in Q1 FY24 and the company’s net profit increased by 2.8% from Rs. 14.2 Cr in Q1 FY23 to Rs. 14.6 Cr in Q1 FY24. As of June 2023, EPS stood at 4.52.
As per the latest shareholding information, promotors hold 27.80%, FIIs hold 5.69%, DIIs hold 19.77% and the public hold a 46.74% stake in the company.
Krsnaa Diagnostics Ltd provides diagnostic services in Radiology and Pathology. It provides diagnostic services to imaging/radiology, routine clinical laboratory tests, pathology, and teleradiology services to private and public hospitals, medical institutions, and community health centres.
Written by Sheshadri N
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.